Table 3.
Immune cells | Cu in immune cell | Cu in tumor immune | Ref. | |
---|---|---|---|---|
Lymphoid lineage | T cell |
Cu↓ → IL-2↓ CuO NPs → Cu↑ → T cell↑ CuO NPs → IFN-γ, IL-4, IL-5↑ |
Cu↓ → JAK/STAT pathway↓ → PD-L1↓ → CD8+T cell and NK cell↑ → tumor suppression copper chelator→ Cu↓→ T cell↑→ tumor suppression LIPT1↑ → PD-L1↑and Treg↓ |
[102, 185–195] |
B cell | Cu↓→circulating B cells↑ | \ | [223] | |
Myeloid lineage | Macrophage |
Cu with 8-hydroxyquinoline → macrophage apoptosis Cu → macrophage polarization → pro-inflammatory M1-type CuO NPs → macrophage death CTMM → regulate macrophage, cuproptosis and ferroptosis →eliminate intracellular infection |
Cu-THBQ/AX → tumor immunogenicity↑ → polarize M2-type to M1-type macrophages and T cell↑ → tumor suppression | [197–208] |
DC | Cu → IL-8↑ | Cu→DCs expression of cGAS-STING pathway related genes↑→tumor suppression | [219–222] | |
MDSC | \ | CuNG → MDSCs apoptosis ↑and ROS in MDSCs↓ → immune response↑ → tumor suppression | [216–218] | |
Neutrophil | Cu↓ → Neutrophils↓ and deformability of neutrophils↓ | MetaCell → release Fe-Cu-MOFs → cuproptosis and ferroptosis → tumor suppression | [209–215] |